Recombinant vectors based on the modified vaccinia anjara (MVA) virus, with deletion in the C6L gene, as vaccines against HIV/AIDS and other diseases

Patent Spanish; Castilian OPEN
García-Arriaza, J.; Gómez, Carmen E.; Esteban, Mariano;
(2011)

[EN] The invention falls within the fields of molecular biology and biotechnology. It specifically relates to recombinant viruses based on the modified vaccinia ankara (MVA) virus, that express the antigens gp120 and Gag-Pol-Nef of the human immunodeficiency virus (VIH-... View more
Share - Bookmark

  • Download from
  • Cite this publication